← FDA Drug Approvals (Drugs@FDA)
CLARITHROMYCIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JUBILANT CADISTA · Approved 2019-04-25
Drug application
- FDA Application #
ANDA206714- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CLARITHROMYCIN
- Generic name
- Clarithromycin
- Active ingredients
- CLARITHROMYCIN
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- JUBILANT CADISTA
- First approval
- 2019-04-25
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown